Abstract
Background: Melatonin is an evolutionarily highly conserved molecule. In humans, exogenous melatonin has been shown to entrain circadian rhythms to light dark cycles and act as an antioxidant. Many complex brain disorders, such as autism and Alzheimer's disease, are associated with abnormal melatonin production or melatonin metabolism. Exogenous melatonin may serve as a potential treatment to improve sleeping patterns and delay neuronal deterioration.
Objective: Here we review the advantages of using zebrafish to study the pharmacology of exogenous melatonin treatments to rescue endogenous melatonin abnormalities.
Method: We perform a literature review to describe the human melatonin system, zebrafish melatonin system, zebrafish advantages as a model organism, and melatonin research using zebrafish.
Conclusions: Zebrafish is a model organism for genetics, physiology, chronobiology, gerontology, and pharmacology studies. Future melatonin research can incorporate all of these fields to better understand melatonin mechanisms in wildtype and mutant zebrafish to discover new potential treatments. A standardized treatment method for all developmental stages should be established to encourage interdisciplinary work.
Keywords: Melatonin, Danio rerio, zebrafish, model organism, exogenous melatonin, sleep disorders, treatment.
Current Psychopharmacology
Title:Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments
Volume: 5
Author(s): Maura Southwell and Scott McRobert
Affiliation:
Keywords: Melatonin, Danio rerio, zebrafish, model organism, exogenous melatonin, sleep disorders, treatment.
Abstract: Background: Melatonin is an evolutionarily highly conserved molecule. In humans, exogenous melatonin has been shown to entrain circadian rhythms to light dark cycles and act as an antioxidant. Many complex brain disorders, such as autism and Alzheimer's disease, are associated with abnormal melatonin production or melatonin metabolism. Exogenous melatonin may serve as a potential treatment to improve sleeping patterns and delay neuronal deterioration.
Objective: Here we review the advantages of using zebrafish to study the pharmacology of exogenous melatonin treatments to rescue endogenous melatonin abnormalities.
Method: We perform a literature review to describe the human melatonin system, zebrafish melatonin system, zebrafish advantages as a model organism, and melatonin research using zebrafish.
Conclusions: Zebrafish is a model organism for genetics, physiology, chronobiology, gerontology, and pharmacology studies. Future melatonin research can incorporate all of these fields to better understand melatonin mechanisms in wildtype and mutant zebrafish to discover new potential treatments. A standardized treatment method for all developmental stages should be established to encourage interdisciplinary work.
Export Options
About this article
Cite this article as:
Southwell Maura and McRobert Scott, Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments, Current Psychopharmacology 2016; 5 (2) . https://dx.doi.org/10.2174/2211556005666160526111529
DOI https://dx.doi.org/10.2174/2211556005666160526111529 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters Tumor Necrosis Factor Inhibitors in Pediatric Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Current Cancer Drug Targets LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery
Current Pharmaceutical Design New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line
Recent Patents on Anti-Cancer Drug Discovery Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
Current Cancer Drug Targets Glycoconjugates in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Gene Therapy of Endometriosis
Recent Patents on DNA & Gene Sequences Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy
Current Cancer Drug Targets Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers
Current Drug Targets Evaluation of Post-Surgical Cognitive Function and Protein Fingerprints in the Cerebro-Spinal Fluid Utilizing Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry (SELDI-TOF MS) After Coronary Artery Bypass Grafting: Review of Proteomic Analytic Tools and Introducing a New Syndrome
Current Medicinal Chemistry The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Antimalarial Drugs in Pregnancy: A Review
Current Drug Safety A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Current Medicinal Chemistry In Vitro and In Vivo Investigations into the Carbene Gold Chloride and Thioglucoside Anticancer Drug Candidates NHC-AuCl and NHC-AuSR
Letters in Drug Design & Discovery Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Mini-Reviews in Medicinal Chemistry